Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Illumina Inc. | 14 | 6 | 0 | 0 | €114.88 | €112.83 | -1.781% |
| Medpace Holdings Inc | 5 | 5 | 1 | 0 | €475.30 | €416.12 | -12.451% |
| Intellia Therapeutics Inc | 25 | 4 | 0 | 1 | €7.69 | €26.70 | 247.255% |
| Amgen Inc. | 26 | 4 | 8 | 0 | €270.75 | €296.66 | 9.570% |
| Lexicon Pharmaceuticals Inc. | 6 | 3 | 0 | 0 | €1.13 | €3.76 | 233.227% |
| Halozyme Therapeutics Inc. | 21 | 2 | 3 | 1 | €53.00 | €67.75 | 27.831% |
| Nektar Therapeutics | 13 | 2 | 1 | 1 | €0.58 | €39.38 | 6661.236% |
| PTC Therapeutics Inc. | 32 | 2 | 0 | 0 | €63.00 | €67.74 | 7.528% |
| Xencor Inc. | 14 | 2 | 1 | 0 | €14.40 | €22.59 | 56.885% |
| Pfizer Inc. | 15 | 2 | 3 | 0 | €22.03 | €27.95 | 26.921% |
| Novartis AG ADR | 7 | 2 | 2 | 0 | €113.00 | €135.30 | 19.738% |
| Bayer AG | 12 | 2 | 3 | 0 | €36.37 | €45.00 | 23.728% |
| Myriad Genetics | 9 | 2 | 1 | 0 | €6.15 | €10.57 | 71.829% |
| UnitedHealth Group Inc. | 73 | 2 | 2 | 0 | €291.20 | €351.33 | 20.650% |
| Regeneron Pharmaceuticals Inc. | 37 | 2 | 4 | 0 | €631.60 | €707.12 | 11.957% |
| Akero Therapeutics Inc | 12 | 2 | 1 | 0 | €46.97 | €68.61 | 46.069% |
| Iovance Biotherapeutics Inc. | 17 | 2 | 0 | 0 | €1.88 | €15.72 | 737.166% |
| Celldex Therapeutics | 11 | 2 | 0 | 0 | €24.00 | €42.18 | 75.758% |
| Fate Therapeutics Inc. | 3 | 2 | 0 | 0 | €0.98 | €3.90 | 296.474% |
| Bristol-Myers Squibb | 4 | 2 | 0 | 1 | €44.67 | €59.59 | 33.397% |
| Sage Therapeutics Inc. | 1 | 2 | 0 | 0 | €7.60 | €6.69 | -11.991% |
| Chimerix Inc. | 3 | 2 | 0 | 0 | €7.52 | €10.56 | 40.390% |
| Roche Holding AG ADR | 4 | 2 | 1 | 1 | €42.59 | €46.97 | 10.279% |
| Lightpath Techs A | 14 | 2 | 0 | 0 | €6.90 | €8.64 | 25.188% |
| WAVE Life Sciences Ltd | 17 | 2 | 3 | 1 | €14.00 | €17.84 | 27.431% |